ArticleRSC advances2023

Discovery of new STAT3 inhibitors as anticancer agents using ligand-receptor contact fingerprints and docking-augmented machine learning.

Nour Jamal Jaradat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.